Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

ALL study, patients transplanted between 2 and 4 years old

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Krzysztof Kalwak

Use of Letermovir after transplant in pediatric patients

Études rétrospectives

Toutes les maladies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini (London)

Impact of Donor and Patient CMV Serology for malignant

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Lymphoïde Chronique (LLC)

Autres tumeurs malignes myéloïdes ou lymphoïdes

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Elif Ince (Ankara)

Impact of the acute GVH on outcomes in ALL

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini (London)

Evaluation of Outcomes following Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with High-Risk Acute Myeloid Leukemia:

Études rétrospectives

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Apparentée

Allogénique - Non apparentée

Allogénique - Haplo-identique

Investigateur principal

Akshay Sharma (Memphis, US)

Prevention and management of conditioning related skin toxicity in paediatric HSCT patients

Closed Survey/Study

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Mihaela Hartmann, Hilda Mekelenkamp

Prévention et gestion de la toxicité cutanée liée à la préparation chez les patients pédiatriques en greffe de cellules souches hématopoïétiques (HSCT)

Toutes les maladies

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Mihaela Hartmann, Hilda Mekelenkamp

Outcomes of HSCT for autoimmune cytopenias (AIC): a Retrospective Registry Study from the Autoimmune Diseases Working Party (ADWP) and the Paediatric Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Allogenic Hematopoietic Stem Cell Transplantation for Adult Sickle Cell Disease: A registry study on behalf of the EBMT Pediatric Disease Working Party

Retrospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Type de traitement

Investigateur principal

Outcomes of allogeneic stem cell transplantation in paediatric patients affected with autosomal dominant RUNX1 mutation related disease

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Giovanna Lucchini

Treo Flu vs Bu Flu +/-Thio in SCD from 2010-2014 (extended to 2017), part of first Medac Study

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Outcome of children developing grade III-IV aGVHD after allogeneic HSCT

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogeneic - Related

Allogeneic - Unrelated

Allogeneic - Haploidentical

Investigateur principal

Giovanna Lucchini